We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

157 hedge funds and large institutions have $720M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more call options, than puts

Call options by funds: $77K | Put options by funds: $11K

86% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 14

8% more funds holding

Funds holding: 145 → 157 (+12)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less capital invested

Capital invested by funds: $792M → $720M (-$72.5M)

11% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 55

Holders
157
Holders Change
+12
Holders Change %
+8.28%
% of All Funds
2.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
49
Reduced
55
Closed
14
Calls
$77K
Puts
$11K
Net Calls
+$66K
Net Calls Change
+$20K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$13.7M
2
GTC
Ghost Tree Capital
New York
+$4.48M
3
JFG
Jefferies Financial Group
New York
+$4.26M
4
Citadel Advisors
Citadel Advisors
Florida
+$3.24M
5
Morgan Stanley
Morgan Stanley
New York
+$3.07M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$11.8M
2
RG
Redmile Group
California
-$5.56M
3
B
Braidwell
Connecticut
-$4.28M
4
ECM
ExodusPoint Capital Management
New York
-$2.82M
5
IC
Ikarian Capital
Texas
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$87.7M +$2.63M +190,580 +3%
BlackRock
2
BlackRock
New York
$69.3M -$262K -18,993 -0.3%
AC
3
Armistice Capital
New York
$58.7M +$717K +52,000 +1%
RG
4
Redmile Group
California
$56.9M -$5.56M -403,182 -8%
Vanguard Group
5
Vanguard Group
Pennsylvania
$55.6M -$329K -23,837 -0.5%
B
6
Braidwell
Connecticut
$42.4M -$4.28M -310,198 -9%
State Street
7
State Street
Massachusetts
$29.4M -$11.8M -858,377 -27%
Goldman Sachs
8
Goldman Sachs
New York
$25.6M -$1.48M -107,527 -5%
PCH
9
Polar Capital Holdings
United Kingdom
$22.3M – – –
Morgan Stanley
10
Morgan Stanley
New York
$20.3M +$3.07M +222,276 +16%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$18.7M +$838K +60,730 +4%
N
12
Nuveen
North Carolina
$16.7M -$551K -39,960 -3%
NLVP
13
New Leaf Venture Partners
New York
$15.4M – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$14.5M +$375K +27,202 +2%
EC
15
EcoR1 Capital
California
$12.6M +$13.7M +993,000 New
Assenagon Asset Management
16
Assenagon Asset Management
Luxembourg
$10.3M -$534K -38,709 -5%
JFG
17
Jefferies Financial Group
New York
$9.4M +$4.26M +308,475 +72%
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$8.99M -$2.04M -148,172 -17%
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$7.61M -$288K -20,868 -3%
PHP
20
Parkman Healthcare Partners
Connecticut
$7.6M +$333K +24,164 +4%
Northern Trust
21
Northern Trust
Illinois
$6.62M +$37.7K +2,731 +0.5%
Charles Schwab
22
Charles Schwab
California
$6.38M +$115K +8,325 +2%
UBS AM
23
UBS AM
Illinois
$5.12M -$185K -13,408 -3%
FLSM
24
Frazier Life Sciences Management
California
$4.71M – – –
Millennium Management
25
Millennium Management
New York
$4.51M +$1.47M +106,253 +43%
1
2 3 4 5

DCPH Hedge Fund Activity: Q3 2023 in Review

157 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q3 2023, worth a combined $720M — down 9.1% from $792M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new DCPH positions and 14 closed out — a net gain of 12 holders — while 49 added to existing stakes and 55 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $13.7M. The largest seller was State Street, cutting an estimated $11.8M.

  • 157 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q3 2023, up from 145 in Q2 2023.
  • Funds reported $720M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q3 2023, down 9.1% quarter-over-quarter.
  • 26 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q3 2023 and 14 closed out, a net change of +12 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q3 2023 was EcoR1 Capital, an estimated $13.7M added.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q3 2023 was State Street, an estimated $11.8M sold.

Based on aggregated 13F filings for Q3 2023.